- Home
- CVAC vs GRC Comparison
CVAC vs GRC Comparison
Compare CVAC & GRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- GRC
- Stock Information
- Founded
- CVAC 2000
- GRC 1933
- Country
- CVAC Germany
- GRC United States
- Employees
- CVAC N/A
- GRC N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- GRC Fluid Controls
- Sector
- CVAC Health Care
- GRC Industrials
- Exchange
- CVAC Nasdaq
- GRC Nasdaq
- Market Cap
- CVAC 1.2B
- GRC 1.2B
- IPO Year
- CVAC 2020
- GRC N/A
- Fundamental
- Price
- CVAC $5.34
- GRC $44.97
- Analyst Decision
- CVAC Hold
- GRC
- Analyst Count
- CVAC 3
- GRC 0
- Target Price
- CVAC $6.83
- GRC N/A
- AVG Volume (30 Days)
- CVAC 574.2K
- GRC 71.7K
- Earning Date
- CVAC 11-12-2025
- GRC 10-24-2025
- Dividend Yield
- CVAC N/A
- GRC 1.69%
- EPS Growth
- CVAC N/A
- GRC 31.51
- EPS
- CVAC 1.01
- GRC 1.91
- Revenue
- CVAC $599,540,810.00
- GRC $678,522,000.00
- Revenue This Year
- CVAC N/A
- GRC $4.94
- Revenue Next Year
- CVAC $23.40
- GRC $4.02
- P/E Ratio
- CVAC $5.32
- GRC $23.58
- Revenue Growth
- CVAC 675.15
- GRC 3.19
- 52 Week Low
- CVAC $2.37
- GRC $30.87
- 52 Week High
- CVAC $5.72
- GRC $49.25
- Technical
- Relative Strength Index (RSI)
- CVAC 51.18
- GRC 47.13
- Support Level
- CVAC $5.17
- GRC $44.08
- Resistance Level
- CVAC $5.41
- GRC $45.65
- Average True Range (ATR)
- CVAC 0.05
- GRC 1.26
- MACD
- CVAC -0.00
- GRC -0.19
- Stochastic Oscillator
- CVAC 70.82
- GRC 20.65
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About GRC Gorman-Rupp Company (The)
Gorman-Rupp Co designs, manufactures, and globally sells pumps & pump systems for use in water, wastewater, construction, dewatering, industrial, petroleum, original equipment, agriculture, fire protection, heating, ventilating & air conditioning, military, and other liquid-handling applications. It operates in one business segment, the manufacture & sale of pumps and pump systems, and generates revenue from the same. Geographically, it generates the majority of revenue from the United States.